Non Motors Aspects in De Novo Parkinson's Disease

• Status: Unknown status
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Clinical description and pathophysiological study of recently diagnosed untreated patients with Parkinson's Disease.

Effect of a dopamine agonist (rotigotine) on apathy in de novo patients with Parkinson disease: A controlled, randomized, double blind study.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Grenoble
• Treatments: N 0437; Rotigotine

Criteria

Inclusion Criteria:

• Patients with Parkinson disease without treatment for Parkinson disease

• Recent diagnosis (< 2 years)

• Without cognitive troubles

Exclusion Criteria:

• Patients with cognitive troubles

• Treated patients with L-Dopa or Dopamine agonists

• Other severe illness

• Pregnant or parturient woman